Dysplastic Nevi as Precursor Melanoma Lesions

Melanins and Melanosomes: Biosynthesis, Biogenesis, Physiological, and Pathological Functions

Volumn , Issue , 2011, Pages 383-393

  Pavel, Stanislav ^a,b   Smit, Nico P M ^b   Pizinger, Karel ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Dysplastic nevi; Melanocyte; Melanocytic nevi; Mutator phenotype; Pheomelanogenesis

Indexed keywords

EID: 84861028124     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527636150.ch13     Document Type: Chapter

References (44)

1. Hussein, M.R. (2005) Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues. J. Clin. Pathol., 58, 453-456.
2. Youl, P., Aitken, J., Hayward, N., Hogg, D., Liu, L., Lassam, N., Martin, M., and Green, A. (2002) Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia. Int. J. Cancer, 98, 92-98.
3. Easton, D.F., Cox, G.M., Macdonald, A.M., and Ponder, B.A. (1991) Genetic susceptibility to naevi-a twin study. Br. J. Cancer, 64, 1164-1167.
4. Gallagher, R.P., McLean, D.I., Yang, P., Coldman, A.J., Silver, H.K.B., Spinelli, J.J., and Beagrie, M. (1990) Suntan, sunburn and pigmentation factors and the frequency of acquired melanocytic nevi in children. Arch. Dermatol., 126, 770-778.
5. Weinstock, M.A., Stryker, W.S., Stampfer, M.J., Lew, R.A., Willett, W.C., and Sober, A.J. (1991) Sunlight and dysplastic nevus risk. Results of a clinic-based case-control study. Cancer, 67, 1701-1706.
6. Hara, K., Nitta, Y., and Ikeya, T. (1992) Dysplastic nevus syndrome among Japanese. A case study and review of the Japanese literature. Am. J. Dermatopathol., 14, 24-31.
7. Clark, W.H.J., Reiemer, R.R., Greene, M.H., Ainsworth, A.A., and Mastrangelo, M.J. (1978) Origin of familial melanomas from heritable melanocytic lesions. " The B-K mole syndrome ". Arch. Dermatol., 114, 732-738.
8. Halpern, A.C., Guerry, D., Elder, D.E., Trock, B., Synnestvedt, M., and Humpreys, T. (1993) Natural history of dysplastic nevi. J. Am. Acad. Dermatol., 29, 51-57.
9. Elder, D. (2010) Dysplastic naevi: an update. Histopathology, 56, 112-120.
10. Gandini, S., Sera, F., Cataruzza, M.S., Pasquini, P., Abeni, D., Boyle, P., and Melchi, C.F. (2005) Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur. J. Cancer, 41, 28-44.
11. Friedman, R.J., Farber, M.J., Warycha, M.A., Papathasis, N., Miller, M.K., and Heilman, E.R. (2009) The " dysplastic " nevus. Clin. Dermatol., 27, 103-115.
12. Sagebiel, R.W. (1993) Melanocytic nevi in histologic association with primary cutaneous melanoma of superfi cial spreading and nodular types: effect of tumor thickness. J. Invest. Dermatol., 100, 322S-325S.
13. Banky, J.P., Kelly, J.P., English, D.R., Yetman, J.M., and Dowling, J.P. (2005) Incidence of new and changed nevi and melanomas detected using baseline images and dermatoscopy in patients at high risk for melanoma. Arch. Dermatol., 141, 998-1006.
14. Argenziano, G., Kittler, H., Ferrara, G., Rubegni, P., Malvehy, J., Puig, S., Cowell, L., Stanganelli, I., De Giorgi, V., Thomas, L., Bahadoran, P., Menzies, S.W., Piccolo, D., Marghoob, A.A., and Zalaudek, I. (2010) Slow-growing melanoma: a dermoscopy follow-up study. Br. J. Dermatol., 162, 267-273.
15. Roth, M., Boyle, J.M., and Mulle, H. (1988) Thymine dimer repair in fi broblasts of patients with dysplastic naevus syndrome (DNS). Experientia, 44, 169-171.
16. Moriwaki, S.-I., Tarone, R.E., and Kramer, K.H. (1994) A potential laboratory test for dysplastic naevus syndrome: ultraviolet hypermutability of a shuttle vector plasmid. J. Invest. Dermatol., 103, 7-12.
17. Vincente Ortega, V., Martinez Diaz, F., Carrascosa Romero, C., and Ortuno Pacheco, G. (1995) Abnormal melanosomes: ultrastructural markers of melanocytic atypia. Ultrastruct. Pathol., 19, 119-128.
18. Takahashi, H., Horikoshi, T., and Jimbow, K. (1985) Fine structural characterization of melanosomes in dysplastic nevi. Cancer, 56, 111-123.
19. Takahashi, H., Yamana, K., Maeda, K., Akutsu, Y., Horikoshi, T., and Jimbow, K. (1987) Dysplastic melanocytic nevus. Electron-microscopic observation as a diagnostic tool. Am. J. Dermatopathol., 9, 189-197.
20. Rhodes, A.R., Seji, M., Fitzpatrick, T.B., and Stern, R.S. (1988) Melanosomal alterations in dysplastic nevi. A quantitative, ultrastructural investigation. Cancer, 61, 358-369.
21. Beitner, H., Nakatani, T., and Hedblad, M.A. (1990) A transition electron microscopical study of dysplastic naevi. Acta. Derm. Venereol., 70, 411-416.
22. Berman, S.B. and Hastings, T.G. (1999) Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implication for Parkinson ' s disease. J. Neurochem., 73, 1127-1137.
23. Hasting, T.G. (2009) The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson ' s disease. J. Bioenerg. Biomembr., 41, 469-472.
24. Zhang, X., Monroe, M.E., Chen, B., Chin, M.H., Heibeck, T.H., Schepmoes, A.A., Yang, F., Petritis, B.O., Camp, D.G., 2nd, Pounds, J.G., Jacobs, J.M., Smit, D.J., Bigelow, D.J., Smith, R.D., and Qian, W.J. (2010) Endogenous 3, 4-dihydroxyphenylalanine and dopaquinone modifi cations on protein tyrosine: links to mitochondrially derived oxidative stress via hydroxyl radical. Mol. Cell. Proteomics, 9, 1199-1208.
25. Czarnecka, A.M., Gammazza, A.M., Di Felice, V., Zummo, G., and Cappello, F. (2007) Cancer as a " mitochondriopathy ". J. Cancer Mol., 3, 71-79.
26. Smit, N.P.M., Van Nieuwpoort, F.A., Marrot, L., Out, C., Poorthuis, B., Van Pelt, H., and Pavel, S. (2008) Increased melanogenesis is a risk factor for oxidative DNA damage-study on cultured melanocytes and atypical nevus cells. J. Invest. Dermatol., 84, 550-555.
27. Eiberger, W., Volkomer, B., Amouroux, R., Dh é rin, C., Pablo Radicella, J., and Epe, B. (2008) Oxidative stress impairs the repair of oxidative DNA base modifi cations in human skin fi broblasts and melanoma cells. DNA Repair, 7, 912-921.
28. Land, E.J. and Riley, P.A. (2000) Spontaneous redox reaction of dopaquinone and the balance between the eumelanic and pheomelanic pathways. P igment Cell Res., 13, 273-277.
29. Ito, S. and Wakamatsu, K. (2008) Chemistry of mixed melanogenesis-pivotal role of dopaquinone. P hotochem. Photobiol., 84, 582-592.
30. van Nieuwpoort, F., Smit, N.P.M., Kolb, A.M., van der Meulen, J., Koerten, H.K., and Pavel, S. (2004) Tyrosine-induced melanogenesis shows differences in morphologic and melanogenic preferences of melanosomes from light and dark skin types. J. Invest. Dermatol., 122, 1251-1255.
31. Pavel, S. and Smit, N.P.M. (1996) Detoxifi cation processes in pigment-producing cells, in Melanogenesis and the Malignant Melanoma: Biochemistry, Cell Biology, Molecular Biology, Pathophysiology, Diagnosis and Treatment (eds Y. Hori, V.J. Hearing, and J. Nakayama), Elsevier, Amsterdam, pp. 161-168.
32. Pavel, S., Smit, N.P.M., van der Meulen, J., Kolb, A.M., De Groot, A., Van der Velden, P.A., Gruis, N.A., and Bergman, W. (2003) Homozygous germline mutation of the CDKN2A/p16 gene and G-6-PD defi ciency in a multiple melanoma case. Melanoma Res., 13, 171-178.
33. Hong, L. and Simon, J.D. (2007) Current understanding of the binding sites, capacity, affi nity, and biological signifi cance of metals in melanin. J. Phys. Chem. B, 111, 7938-7947.
34. Pavel, S., van Nieuwpoort, F., van der Meulen, J., Out, C., Pizinger, K., Cetkovsk á, P., Smit, N.P.M., and Koerten, H.K. (2004) Disturbed melanin synthesis and chronic oxidative stress in melanoma precursor lesions. Eur. J. Cancer, 40, 1423-1430.
35. Mooi, W.J. and Peeper, D.S. (2006) Oncogene-induced cell senescence-halting on the road to cancer. N. Engl. J. Med., 355, 1037-1046.
36. Ben Porath, I. and Weinberg, R.A. (2005) The signals and pathways activating cellular senescence. Int. J. Biochem. Cell Biol., 37, 961-976.
37. Ha, L., Merlino, G., and Sviderskaya, E.V. (2008) Melanomagenesis. Overcoming the barrier of melanocyte senescence. Cell Cycle, 7, 1944-1948.
38. Loeb, L.A., Springgate, C.F., and Battula, N. (1974) Errors in DNA replications as a basis of malignant change. Cancer Res., 34, 2311-2321.
39. Loeb, L.A., Bielas, J.H., and Beckman, R.A. (2008) Cancers exhibit a mutator phenotype: clinical implications. Cancer Res., 68, 3551-3561.
40. Schwartz, S., Jr, Yamamota, H., Navarro, M., Maestro, M., and Perucho, M. (1999) Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. C ancer Res., 59, 2995-3002.
41. Colombo, P., Patriarca, C., Alfano, R.M., Cassani, B., Ceva Grimaldi, G., Roncalli, M., Bosari, S., Coggi, G., Campo, B., and Gould, V.E. (2001) Molecular disorders in transitional vs. peripheral zone prostate adenocarcinoma. Int. J. Cancer, 94, 383-389.
42. Abdel-Rahman, W.M. (2008) Genomic instability and carcinogenesis: an update. Curr. Genomics, 9, 535-541.
43. Traupe, H., Macher, E., Hamm, H., and Happle, R. (1989) Mutation rate estimates are not compatible with autosomal dominant inheritance of the dysplastic nevus " syndrome ". Am. J. Med. Genet., 32, 155-157.
44. Dayal, D., Martin, S.M., Limoli, C.L., and Spitz, D.R. (2008) Hydrogen peroxide mediates the radiation-induced mutator phenotype in mammalian cells. Biochem. J., 413, 185-191.